A real-world, multicentre, retrospective study of first-line pembrolizumab in black patients with metastatic non-small cell lung cancer
Latest Information Update: 15 Oct 2021
At a glance
- Drugs Antineoplastics (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 15 Oct 2021 New trial record